Prevention and treatment of cardiovascular disease in HIV: practical insights in an evolving field
Top Antivir Med. 2023 Dec 5;31(5):559-565.ABSTRACTPeople with HIV (PWH) are at higher risk for cardiovascular disease (CVD) than people without HIV. As antiretroviral therapy (ART) and the natural history of HIV have evolved, so have the pathogenesis and manifestations of HIV-associated CVD. Epidemiologic data from several cohorts demonstrate that PWH have an approximately 50% higher risk than people without HIV for CVD, including, but not limited to, myocardial infarction and heart failure. This elevated CVD risk is not universal among PWH; for instance, the risk is higher among individuals with a history of sustained uns...
Source: Topics in antiviral medicine - January 10, 2024 Category: Infectious Diseases Authors: Harris Avgousti Matthew J Feinstein Source Type: research
Doxycycline postexposure prophylaxis for prevention of sexually transmitted infections
Top Antivir Med. 2023 Dec 5;31(5):566-575.ABSTRACTDoxycycline postexposure prophylaxis (doxy-PEP) is a novel strategy now demonstrated in several clinical trials to dramatically reduce incidence rates of gonorrhea, chlamydia, and syphilis in some key populations at high risk of sexually transmitted infections. Even so, much remains unknown about the long-term consequences of doxy-PEP, and several concerns, including the potential for the development of antibiotic resistance and disturbances to the microbiome, balance the benefits. This review highlights the history of antibiotic prophylaxis for sexually transmitted infecti...
Source: Topics in antiviral medicine - January 10, 2024 Category: Infectious Diseases Authors: Chase A Cannon Connie L Celum Source Type: research
2023 updated guidelines on infant feeding and HIV in the United States: what are they and why have recommendations changed
Top Antivir Med. 2023 Dec 5;31(5):576-586.ABSTRACTThe US Department of Health and Human Services guidelines on infant feeding among people with HIV have changed in response to (1) evidence of low risk of transmission via breast milk among individuals with consistent viral suppression, (2) considerations of equity and cultural norms, and (3) community desires. The 2023 guidelines recommend patient-centered shared decision-making. Individuals with HIV who are receiving antiretroviral therapy (ART) and have consistent viral suppression should be counseled on the options of for-mula feeding, feeding with banked donor milk, or ...
Source: Topics in antiviral medicine - January 10, 2024 Category: Infectious Diseases Authors: Lealah Pollock July Levison Source Type: research
Prevention and treatment of cardiovascular disease in HIV: practical insights in an evolving field
Top Antivir Med. 2023 Dec 5;31(5):559-565.ABSTRACTPeople with HIV (PWH) are at higher risk for cardiovascular disease (CVD) than people without HIV. As antiretroviral therapy (ART) and the natural history of HIV have evolved, so have the pathogenesis and manifestations of HIV-associated CVD. Epidemiologic data from several cohorts demonstrate that PWH have an approximately 50% higher risk than people without HIV for CVD, including, but not limited to, myocardial infarction and heart failure. This elevated CVD risk is not universal among PWH; for instance, the risk is higher among individuals with a history of sustained uns...
Source: Topics in antiviral medicine - January 10, 2024 Category: Infectious Diseases Authors: Harris Avgousti Matthew J Feinstein Source Type: research
Doxycycline postexposure prophylaxis for prevention of sexually transmitted infections
Top Antivir Med. 2023 Dec 5;31(5):566-575.ABSTRACTDoxycycline postexposure prophylaxis (doxy-PEP) is a novel strategy now demonstrated in several clinical trials to dramatically reduce incidence rates of gonorrhea, chlamydia, and syphilis in some key populations at high risk of sexually transmitted infections. Even so, much remains unknown about the long-term consequences of doxy-PEP, and several concerns, including the potential for the development of antibiotic resistance and disturbances to the microbiome, balance the benefits. This review highlights the history of antibiotic prophylaxis for sexually transmitted infecti...
Source: Topics in antiviral medicine - January 10, 2024 Category: Infectious Diseases Authors: Chase A Cannon Connie L Celum Source Type: research
2023 updated guidelines on infant feeding and HIV in the United States: what are they and why have recommendations changed
Top Antivir Med. 2023 Dec 5;31(5):576-586.ABSTRACTThe US Department of Health and Human Services guidelines on infant feeding among people with HIV have changed in response to (1) evidence of low risk of transmission via breast milk among individuals with consistent viral suppression, (2) considerations of equity and cultural norms, and (3) community desires. The 2023 guidelines recommend patient-centered shared decision-making. Individuals with HIV who are receiving antiretroviral therapy (ART) and have consistent viral suppression should be counseled on the options of for-mula feeding, feeding with banked donor milk, or ...
Source: Topics in antiviral medicine - January 10, 2024 Category: Infectious Diseases Authors: Lealah Pollock July Levison Source Type: research
Prevention and treatment of cardiovascular disease in HIV: practical insights in an evolving field
Top Antivir Med. 2023 Dec 5;31(5):559-565.ABSTRACTPeople with HIV (PWH) are at higher risk for cardiovascular disease (CVD) than people without HIV. As antiretroviral therapy (ART) and the natural history of HIV have evolved, so have the pathogenesis and manifestations of HIV-associated CVD. Epidemiologic data from several cohorts demonstrate that PWH have an approximately 50% higher risk than people without HIV for CVD, including, but not limited to, myocardial infarction and heart failure. This elevated CVD risk is not universal among PWH; for instance, the risk is higher among individuals with a history of sustained uns...
Source: Topics in antiviral medicine - January 10, 2024 Category: Infectious Diseases Authors: Harris Avgousti Matthew J Feinstein Source Type: research
Doxycycline postexposure prophylaxis for prevention of sexually transmitted infections
Top Antivir Med. 2023 Dec 5;31(5):566-575.ABSTRACTDoxycycline postexposure prophylaxis (doxy-PEP) is a novel strategy now demonstrated in several clinical trials to dramatically reduce incidence rates of gonorrhea, chlamydia, and syphilis in some key populations at high risk of sexually transmitted infections. Even so, much remains unknown about the long-term consequences of doxy-PEP, and several concerns, including the potential for the development of antibiotic resistance and disturbances to the microbiome, balance the benefits. This review highlights the history of antibiotic prophylaxis for sexually transmitted infecti...
Source: Topics in antiviral medicine - January 10, 2024 Category: Infectious Diseases Authors: Chase A Cannon Connie L Celum Source Type: research
2023 updated guidelines on infant feeding and HIV in the United States: what are they and why have recommendations changed
Top Antivir Med. 2023 Dec 5;31(5):576-586.ABSTRACTThe US Department of Health and Human Services guidelines on infant feeding among people with HIV have changed in response to (1) evidence of low risk of transmission via breast milk among individuals with consistent viral suppression, (2) considerations of equity and cultural norms, and (3) community desires. The 2023 guidelines recommend patient-centered shared decision-making. Individuals with HIV who are receiving antiretroviral therapy (ART) and have consistent viral suppression should be counseled on the options of for-mula feeding, feeding with banked donor milk, or ...
Source: Topics in antiviral medicine - January 10, 2024 Category: Infectious Diseases Authors: Lealah Pollock July Levison Source Type: research
Prevention and treatment of cardiovascular disease in HIV: practical insights in an evolving field
Top Antivir Med. 2023 Dec 5;31(5):559-565.ABSTRACTPeople with HIV (PWH) are at higher risk for cardiovascular disease (CVD) than people without HIV. As antiretroviral therapy (ART) and the natural history of HIV have evolved, so have the pathogenesis and manifestations of HIV-associated CVD. Epidemiologic data from several cohorts demonstrate that PWH have an approximately 50% higher risk than people without HIV for CVD, including, but not limited to, myocardial infarction and heart failure. This elevated CVD risk is not universal among PWH; for instance, the risk is higher among individuals with a history of sustained uns...
Source: Topics in antiviral medicine - January 10, 2024 Category: Infectious Diseases Authors: Harris Avgousti Matthew J Feinstein Source Type: research
Doxycycline postexposure prophylaxis for prevention of sexually transmitted infections
Top Antivir Med. 2023 Dec 5;31(5):566-575.ABSTRACTDoxycycline postexposure prophylaxis (doxy-PEP) is a novel strategy now demonstrated in several clinical trials to dramatically reduce incidence rates of gonorrhea, chlamydia, and syphilis in some key populations at high risk of sexually transmitted infections. Even so, much remains unknown about the long-term consequences of doxy-PEP, and several concerns, including the potential for the development of antibiotic resistance and disturbances to the microbiome, balance the benefits. This review highlights the history of antibiotic prophylaxis for sexually transmitted infecti...
Source: Topics in antiviral medicine - January 10, 2024 Category: Infectious Diseases Authors: Chase A Cannon Connie L Celum Source Type: research
2023 updated guidelines on infant feeding and HIV in the United States: what are they and why have recommendations changed
Top Antivir Med. 2023 Dec 5;31(5):576-586.ABSTRACTThe US Department of Health and Human Services guidelines on infant feeding among people with HIV have changed in response to (1) evidence of low risk of transmission via breast milk among individuals with consistent viral suppression, (2) considerations of equity and cultural norms, and (3) community desires. The 2023 guidelines recommend patient-centered shared decision-making. Individuals with HIV who are receiving antiretroviral therapy (ART) and have consistent viral suppression should be counseled on the options of for-mula feeding, feeding with banked donor milk, or ...
Source: Topics in antiviral medicine - January 10, 2024 Category: Infectious Diseases Authors: Lealah Pollock July Levison Source Type: research
Prevention and treatment of cardiovascular disease in HIV: practical insights in an evolving field
Top Antivir Med. 2023 Dec 5;31(5):559-565.ABSTRACTPeople with HIV (PWH) are at higher risk for cardiovascular disease (CVD) than people without HIV. As antiretroviral therapy (ART) and the natural history of HIV have evolved, so have the pathogenesis and manifestations of HIV-associated CVD. Epidemiologic data from several cohorts demonstrate that PWH have an approximately 50% higher risk than people without HIV for CVD, including, but not limited to, myocardial infarction and heart failure. This elevated CVD risk is not universal among PWH; for instance, the risk is higher among individuals with a history of sustained uns...
Source: Topics in antiviral medicine - January 10, 2024 Category: Infectious Diseases Authors: Harris Avgousti Matthew J Feinstein Source Type: research
Doxycycline postexposure prophylaxis for prevention of sexually transmitted infections
Top Antivir Med. 2023 Dec 5;31(5):566-575.ABSTRACTDoxycycline postexposure prophylaxis (doxy-PEP) is a novel strategy now demonstrated in several clinical trials to dramatically reduce incidence rates of gonorrhea, chlamydia, and syphilis in some key populations at high risk of sexually transmitted infections. Even so, much remains unknown about the long-term consequences of doxy-PEP, and several concerns, including the potential for the development of antibiotic resistance and disturbances to the microbiome, balance the benefits. This review highlights the history of antibiotic prophylaxis for sexually transmitted infecti...
Source: Topics in antiviral medicine - January 10, 2024 Category: Infectious Diseases Authors: Chase A Cannon Connie L Celum Source Type: research
2023 updated guidelines on infant feeding and HIV in the United States: what are they and why have recommendations changed
Top Antivir Med. 2023 Dec 5;31(5):576-586.ABSTRACTThe US Department of Health and Human Services guidelines on infant feeding among people with HIV have changed in response to (1) evidence of low risk of transmission via breast milk among individuals with consistent viral suppression, (2) considerations of equity and cultural norms, and (3) community desires. The 2023 guidelines recommend patient-centered shared decision-making. Individuals with HIV who are receiving antiretroviral therapy (ART) and have consistent viral suppression should be counseled on the options of for-mula feeding, feeding with banked donor milk, or ...
Source: Topics in antiviral medicine - January 10, 2024 Category: Infectious Diseases Authors: Lealah Pollock July Levison Source Type: research
